Literature DB >> 34240669

Effects of resistance training on quality of life in postmenopausal women with vasomotor symptoms.

E Berin1, M Hammar1, H Lindblom2, L Lindh-Åstrand1, A-C Spetz Holm1.   

Abstract

OBJECTIVE: Most women experience vasomotor symptoms (VMS) around menopause that may affect quality of life negatively. Effective pharmacological treatment exists but is not recommended for all women, and there is a demand for alternatives to reduce symptoms and improve quality of life. The objective of this study was to investigate the effect of a resistance training intervention on health-related quality of life (HRQoL) in postmenopausal women with VMS.
METHODS: This open randomized controlled trial included 65 postmenopausal women >45 years old with daily VMS. The participants were randomized to 15 weeks of resistance training three times per week or an untreated control group. The Women's Health Questionnaire (WHQ) and Short Form Health Survey (SF-36) were used to assess HRQoL at baseline and after 15 weeks.
RESULTS: The resistance training group improved compared to the control group in the WHQ domains of VMS (p = 0.002), sleep problems (p = 0.003) and menstrual symptoms (p = 0.01) from baseline to post intervention. No significant between-group differences were found in SF-36 summary scores, or in any of the domains.
CONCLUSION: In postmenopausal women with moderate to severe VMS, resistance training three times per week for 15 weeks improved menopause-specific HRQoL.

Entities:  

Keywords:  Menopause; exercise; hot flushes; patient reported outcome measures; quality of life; resistance training; strength training; vasomotor symptoms

Mesh:

Year:  2021        PMID: 34240669     DOI: 10.1080/13697137.2021.1941849

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.024


  1 in total

1.  Postmenopausal women's experiences of a resistance training intervention against vasomotor symptoms: a qualitative study.

Authors:  Emilia Berin; Anna-Clara Spetz Holm; Mats Hammar; Lotta Lindh-Åstrand; Carina Berterö
Journal:  BMC Womens Health       Date:  2022-07-30       Impact factor: 2.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.